Education
About Us
Working with TipRanks
Follow Us
The United Laboratories International Holdings Limited (HK:3933)
:3933
3933 Stock Chart & Stats
HK$11.74
HK$0.26(2.23%)
At close: 4:00 PM EST
HK$11.74
HK$0.26(2.23%)
Day’s Range― - ―
52-Week RangeHK$11.02 - HK$17.98
Previous CloseN/A
Volume6.42M
Average Volume (3M)9.98M
Market Cap
HK$24.84B
Enterprise ValueHK$18.05B
Total Cash (Recent Filing)HK$9.01B
Total Debt (Recent Filing)HK$5.13B
Price to Earnings (P/E)6.9
Beta0.74
Next Earnings
Mar 31, 2026EPS Estimate
0.25Next Dividend Ex-DateN/A
Dividend Yield5.11%
Share Statistics
EPS (TTM)1.18
Shares Outstanding1,973,026,500
10 Day Avg. Volume7,816,257
30 Day Avg. Volume9,977,158
Financial Highlights & Ratios
PEG Ratio-3.94
Price to Book (P/B)1.47
Price to Sales (P/S)1.53
P/FCF Ratio15.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthConsistent revenue growth indicates strong market demand and effective business strategies, supporting long-term financial stability and expansion.
Balance Sheet StrengthA strong equity position with low debt enhances financial resilience, providing the company with the flexibility to invest in growth opportunities.
ProfitabilityRobust profit margins reflect effective cost management and operational efficiency, ensuring sustainable profitability and competitive advantage.
Bears Say
Cash Flow ManagementFluctuating cash flow and recent data gaps pose challenges to financial stability, potentially impacting the company's ability to fund operations and growth.
Return On Equity FluctuationsFluctuations in return on equity indicate potential inefficiencies, which could affect investor confidence and long-term financial performance.
EBIT And EBITDA Margin DecreaseDecreasing EBIT and EBITDA margins, though still healthy, may signal rising costs or competitive pressures, affecting future profitability.
The United Laboratories International Holdings News
3933 FAQ
What was The United Laboratories International Holdings Limited’s price range in the past 12 months?
The United Laboratories International Holdings Limited lowest stock price was HK$11.02 and its highest was HK$17.98 in the past 12 months.
What is The United Laboratories International Holdings Limited’s market cap?
The United Laboratories International Holdings Limited’s market cap is HK$24.84B.
When is The United Laboratories International Holdings Limited’s upcoming earnings report date?
The United Laboratories International Holdings Limited’s upcoming earnings report date is Mar 31, 2026 which is in 39 days.
How were The United Laboratories International Holdings Limited’s earnings last quarter?
The United Laboratories International Holdings Limited released its earnings results on Aug 28, 2025. The company reported HK$1.18 earnings per share for the quarter, missing the consensus estimate of HK$1.504 by -HK$0.325.
Is The United Laboratories International Holdings Limited overvalued?
According to Wall Street analysts The United Laboratories International Holdings Limited’s price is currently Overvalued.
Does The United Laboratories International Holdings Limited pay dividends?
The United Laboratories International Holdings Limited pays a Annually dividend of HK$0.175 which represents an annual dividend yield of 5.11%. See more information on The United Laboratories International Holdings Limited dividends here
What is The United Laboratories International Holdings Limited’s EPS estimate?
The United Laboratories International Holdings Limited’s EPS estimate is 0.25.
How many shares outstanding does The United Laboratories International Holdings Limited have?
The United Laboratories International Holdings Limited has 1,973,026,500 shares outstanding.
What happened to The United Laboratories International Holdings Limited’s price movement after its last earnings report?
The United Laboratories International Holdings Limited reported an EPS of HK$1.18 in its last earnings report, missing expectations of HK$1.504. Following the earnings report the stock price went down -4.787%.
Which hedge fund is a major shareholder of The United Laboratories International Holdings Limited?
Currently, no hedge funds are holding shares in HK:3933
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
The United Laboratories International Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.38%
12-Months-Change
Fundamentals
Return on Equity
21.02%
Trailing 12-Months
Asset Growth
30.76%
Trailing 12-Months
Company Description
The United Laboratories International Holdings Limited
The United Laboratories International Holdings Limited (3933) is a Hong Kong-based company primarily engaged in the manufacturing and distribution of pharmaceuticals, including generic and branded drugs. The company operates in various sectors such as healthcare, biotechnology, and consumer products, providing a wide range of pharmaceutical products, including traditional Chinese medicine, over-the-counter medications, and medical devices. United Laboratories focuses on innovation and quality, aiming to meet the growing healthcare demands in both domestic and international markets.
Technical Analysis
HUTCHMED (China)
―
China Medical System Holdings
―
Livzon Pharmaceutical Group
―
China Resources Pharmaceutical Group Ltd.
―
Grand Pharmaceutical Group Limited
―
Options Prices
Currently, No data available
---